Abstract
Evaluating and responding to new information requires cognitive control. Here, we studied novelty-response mechanisms in Parkinson’s disease (PD). In PD patient-volunteers, we recorded from cortical circuits with scalp-based electroencephalography (EEG) and from subcortical circuits using intraoperative neurophysiology during surgeries for implantation of deep-brain stimulation (DBS) electrodes. We report three major results. First, novel auditory stimuli triggered midfrontal ∼4-Hz rhythms, which were attenuated in PD patients but were not linked with cognitive function or novelty-associated slowing. Second, 32% of subthalamic nucleus (STN) neurons were response-modulated; nearly all (94%) of these were also modulated by novel stimuli. Finally, response-modulated STN neurons were coherent with midfrontal low- frequency activity. These findings link scalp-based measurements of neural activity with neuronal activity in the STN. Our results provide insight into midfrontal cognitive control mechanisms and how hyperdirect circuits evaluate new information.
Significance statement Parkinson’s disease (PD) is a neurodegenerative disorder with motor and cognitive symptoms. Here we studied how the brain recruits cognitive control in response to new information. We found that PD patients have decreased cortical low-frequency oscillations linked to cognitive control. We also examined single neurons in PD patients in a deep brain structure called the subthalamic nucleus, and found that response-modulated neurons were uniquely modulated by novelty and they fired in-phase with these same low-frequency brain oscillations. Our work helps illustrate how neural circuits evaluate new information, which could be relevant for PD as well as other diseases that disrupt cognition.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
-
Funding Statement
NIH NINDS
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Iowa IRB
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The authors declare no competing financial interests.
